Candriam S.C.A. Medpace Holdings, Inc. Transaction History
Candriam S.C.A.
- $17.1 Billion
- Q3 2024
A detailed history of Candriam S.C.A. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Candriam S.C.A. holds 83,281 shares of MEDP stock, worth $27.9 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
83,281
Previous 74,561
11.7%
Holding current value
$27.9 Million
Previous $30.7 Million
9.55%
% of portfolio
0.16%
Previous 0.19%
Shares
7 transactions
Others Institutions Holding MEDP
# of Institutions
615Shares Held
25MCall Options Held
41.7KPut Options Held
205K-
Black Rock Inc. New York, NY2.58MShares$863 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.55MShares$852 Million0.02% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT909KShares$304 Million1.51% of portfolio
-
State Street Corp Boston, MA753KShares$252 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA628KShares$210 Million0.02% of portfolio
About Medpace Holdings, Inc.
- Ticker MEDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 31,099,900
- Market Cap $10.4B
- Description
- Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...